首页> 美国卫生研究院文献>Critical Care >Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure
【2h】

Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure

机译:MARS和Prometheus体外肝支持对急性慢性肝衰竭患者血清细胞因子的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionCytokines are believed to play an important role in acute-on-chronic liver failure (ACLF). Extracorporeal liver support systems may exert beneficial effects in ACLF via removal of cytokines. At present, two systems are commercially available, the Molecular Adsorbent Recirculating System (MARS™) and Fractionated Plasma Separation, Adsorption and Dialysis (Prometheus™). The aim of this study was to compare the effects of MARS and Prometheus treatments on serum cytokine levels and their clearances.
机译:简介细胞因子被认为在慢性慢性肝衰竭(ACLF)中起着重要作用。体外肝支持系统可通过去除细胞因子在ACLF中发挥有益作用。目前,有两种系统可商购,分子吸附剂再循环系统(MARS™)和等离子分离,吸附和透析(Prometheus™)。本研究的目的是比较MARS和Prometheus治疗对血清细胞因子水平及其清除率的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号